Shorter duration of common colds for endurance athletes with ColdZyme
A British study initiated by researchers in which endurance athletes used Enzymatica’s ColdZyme®[®] cold spray shows significantly shorter duration of common colds and milder common cold symptoms compared with endurance athletes in the untreated group. The study, which was published in the European Journal of Sport Science, was conducted at the University of Kent. The results confirm the interim data from 2018, as well as results from earlier studies on ColdZyme.In this prospective observational study, which is the first randomized and controlled study investigating the effect of ColdZyme